| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/20/2001 | CN1299670A Plaster and its preparation |
| 06/20/2001 | CN1299669A Chinese medicine for treating several kinds of common ailment |
| 06/20/2001 | CN1299661A Chinese medicine for treating various hemorrhagic diseases caused by reduced prothrombin |
| 06/20/2001 | CN1067384C Adhesion receptor antagonists, its preparation method and use as farm chemicals |
| 06/20/2001 | CN1067247C Use of sodium alginate diester in medicine for preventing and curing thrombocytopenia and leukopenia |
| 06/19/2001 | US6248785 IL-8 receptor antagonists |
| 06/19/2001 | US6248765 Imidazole derivatives as histamine receptor H3 (ANT) agonists |
| 06/19/2001 | US6248712 Urokinase-type plasminogen activator receptor |
| 06/19/2001 | US6248548 Thrombosis prophylaxis for factor Vleiden carriers |
| 06/19/2001 | US6248363 Improved delivery of hydrophilic or hydrophobic pharmaceutical active ingredients, such as drugs, nutraceuticals, cosmeceuticals and diagnostic agents |
| 06/19/2001 | US6248318 Method for treating hypercholesterolemia with unsubstituted polydiallylamine polymers |
| 06/19/2001 | CA2172187C Method of incorporating drugs into a polymer component of stents |
| 06/14/2001 | WO2001042471A2 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | WO2001042449A2 Methods for introducing genes into mammalian subjects |
| 06/14/2001 | WO2001042368A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | WO2001042305A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | WO2001042288A2 G-protein coupled receptors |
| 06/14/2001 | WO2001042262A2 Antithrombotic compound |
| 06/14/2001 | WO2001042254A1 Benzamidine derivatives |
| 06/14/2001 | WO2001042241A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/14/2001 | WO2001042224A1 Carboxyamido derivatives |
| 06/14/2001 | WO2001042216A2 Caspase inhibitors and uses thereof |
| 06/14/2001 | WO2001042209A1 Process for the preparation of amorphous atorvastatin |
| 06/14/2001 | WO2001042199A1 Amidinophenylpyruvic acid derivative |
| 06/14/2001 | WO2001041803A1 COMBINATION OF COMPOUNDS THAT INHIBIT THE BIOLOGICAL EFFECTS OF TNF-α AND CD95L IN A MEDICAMENT |
| 06/14/2001 | WO2001041794A2 Activated amylase |
| 06/14/2001 | WO2001041791A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 06/14/2001 | WO2001041774A1 Haemostatic bactericidal compositions |
| 06/14/2001 | WO2001041762A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041761A2 Valdecoxib compositions |
| 06/14/2001 | WO2001041754A2 Inhibitors of collagen-induced platelet aggregation |
| 06/14/2001 | WO2001018040A3 Use of leptin in inhibition of endothelial cell proliferation |
| 06/14/2001 | WO2001016133A3 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
| 06/14/2001 | WO2001003720A3 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 06/14/2001 | WO2001000812A3 22012, a novel human carboxypeptidase |
| 06/14/2001 | US20010003742 Antilipemic formulation |
| 06/14/2001 | US20010003740 Method of treating thrombocytopenic purpura and hemolytic uremic syndrome |
| 06/14/2001 | CA2733434A1 Caspase inhibitors and uses thereof |
| 06/14/2001 | CA2394917A1 Polypeptides and polynucleotides encoding same |
| 06/14/2001 | CA2394891A1 Substituted phthalocyanines and their precursors |
| 06/14/2001 | CA2393779A1 Combination of compounds that inhibit the biological effects of tnf-.alpha. and cd95l in a medicament |
| 06/14/2001 | CA2393661A1 Interleukin-1 receptor antagonist-like molecules and uses thereof |
| 06/14/2001 | CA2393463A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 06/14/2001 | CA2392961A1 G-protein coupled receptors |
| 06/14/2001 | CA2392584A1 Substituted pyridazines having cytokine inhibitory activity |
| 06/14/2001 | CA2390857A1 Inhibitors of collagen-induced platelet aggregation |
| 06/14/2001 | CA2383001A1 Methods for introducing genes into mammalian subjects |
| 06/13/2001 | EP1106615A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106614A1 5-Membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/13/2001 | EP1106606A2 N-(3-piperidinylcarbonyl)-beta-alanine derivatives as paf antagonists |
| 06/13/2001 | EP1105506A1 Adenoviral vectors encoding erythropoietin and their use in gene therapy |
| 06/13/2001 | EP1105478A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 06/13/2001 | EP1105475A1 Tissue factor protein variants with increased affinity for coagulation factor fvii/fviia |
| 06/13/2001 | EP1105412A1 Serine protease inhibitors comprising alpha-keto heterocycles |
| 06/13/2001 | EP1105410A1 Purification of blood clotting proteins |
| 06/13/2001 | EP1105384A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors |
| 06/13/2001 | EP1105371A2 Novel aryl sulphonamide amino acid esters and analogues |
| 06/13/2001 | EP1105370A1 Novel aryl sulphonamides and analogues |
| 06/13/2001 | EP1105152A1 Tnf-derived peptides for use in treating oedema |
| 06/13/2001 | DE19956156A1 Verfahren zur Aufbereitung eines Präparates von Thrombozyten und Thrombozytenpräparat Process for the preparation of a preparation of platelets and platelet preparation |
| 06/13/2001 | CN1299359A Benzofurylpyrone derivatives |
| 06/13/2001 | CN1299343A Biphenyl derivatives |
| 06/13/2001 | CN1298715A Hematopoietic oral liquid and its preparing process |
| 06/13/2001 | CN1067104C Method for prepn. of secretion of hirudin derivatives |
| 06/13/2001 | CN1066961C Preparing of pharmaceutical with activity of resolution of thrombus by use of agent directly inhibiting thrombin |
| 06/13/2001 | CN1066953C Drug for curing subdermal implantation postoperative endometrorrhagia and its prepn. method |
| 06/12/2001 | US6245914 Efficient method for the conversion of nitriles to amidines and species thereof |
| 06/12/2001 | US6245790 Oxazole compounds useful as PGE2 agonists and antagonists |
| 06/12/2001 | US6245776 Drug mixture of immune response modifier, fatty acid, preservative and carbomer |
| 06/12/2001 | US6245763 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 06/12/2001 | US6245741 Protein Z-dependent protease inhibitor |
| 06/12/2001 | US6245526 Mammalian nucleotide sequences which code polypeptides for the classification, diagnosis, treatment, and prevention of cell proliferative and lipid defects |
| 06/12/2001 | CA2171453C Glutathione analogs and paralog panels comprising glutathione mimics |
| 06/12/2001 | CA2044978C Platelet-aggregation inhibitor |
| 06/10/2001 | CA2327946A1 Substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/10/2001 | CA2327925A1 5-membered heteroaryl substituted 1,4-dihydropyridine compounds as bradykinin antagonists |
| 06/07/2001 | WO2001040456A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | WO2001040231A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 06/07/2001 | WO2001040230A1 Pyrazolopyrazines and their use as adenosine antagonists |
| 06/07/2001 | WO2001040216A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | WO2001040204A1 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient |
| 06/07/2001 | WO2001040201A1 Oxazolidinone derivatives |
| 06/07/2001 | WO2001039781A1 Pharmaceutical combinations |
| 06/07/2001 | WO2001039777A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | WO2001039773A1 Thrombopoietin mimetics |
| 06/07/2001 | WO2001039766A2 Screening invertebrate pheromones for therapeutic activity |
| 06/07/2001 | WO2001015654A3 Low molecular weight antithrombotic polysaccharide |
| 06/07/2001 | WO2001012213A3 Ttp-related zinc finger domains and methods of use |
| 06/07/2001 | WO2001007612A3 Receptors and associated proteins |
| 06/07/2001 | WO2001001775A8 Preserving a hemoglobin blood substitute with a transparent overwrap |
| 06/07/2001 | DE19958153A1 Oxazolidinon-Derivate Oxazolidinone derivatives |
| 06/07/2001 | DE19955607A1 Medikament oder aufeinander abgestimmte Kombination von Medikamenten Drug or combination of drugs concerted |
| 06/07/2001 | CA2393217A1 Oxazolidinone derivatives |
| 06/07/2001 | CA2393179A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
| 06/07/2001 | CA2392931A1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents |
| 06/07/2001 | CA2392717A1 Cytokine receptor-like polynucleotides, polypeptides, and antibodies |
| 06/07/2001 | CA2390786A1 Compositions and methods for the treatment of immune related diseases |
| 06/06/2001 | EP1104760A1 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104759A1 Heteroaryl phenyl pyrazole compounds as anti-inflammatory/analgesic agents |
| 06/06/2001 | EP1104758A1 Acetylene derivatives as anti-inflammatory/analgesic agents |